Kiora Pharmaceuticals Inc. buy BiotechBee
Start price
04.02.24
/
60%
€0.69
Target price
31.12.25
€1.00
Performance (%)
-37.75%
Price
10.06.24
€0.42
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Kiora Pharmaceuticals Inc. is performing very badly with a performance of -37.75%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Kiora Pharmaceuticals Inc. | - | - |
iShares Core DAX® | 2.758% | 0.818% |
iShares Nasdaq 100 | 2.595% | -1.326% |
iShares Nikkei 225® | 3.109% | 0.173% |
iShares S&P 500 | 1.862% | -0.531% |
According to BiotechBee what are the pros and cons of Kiora Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Kiora Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 1,0